Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts

Oncogene

Volumn 19, Issue 9, 2000, Pages 1173-1180

  Schuster, Ralph ^a   Gerlich, Wolfram H ^a   Schaefer, Stephan ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Apoptosis; Bcl 2; E1B; HBV; HBx; HCC

Indexed keywords

MUTANT PROTEIN; MYC PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P35; RAS PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENETIC TRANSFECTION; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SIMIAN VIRUS 40; TRANSACTIVATION; VIRUS CARCINOGENESIS; VIRUS GENE;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0034708234     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203417     Document Type: Article

References (62)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K. (eds). (1998). Current Protocols in Molecular Biology. John Wiley and Sons, Inc. pp. 914-916.
2. Avantaggiati ML, Natoli G, Balsano C, Chirillo P, Artini M, De Marzio E, Collepardo D and Levrero M. (1993). Oncogene, 8, 1567-1574.
3. Benn J, Su F, Doria M and Schneider RJ. (1996). J. Virol., 70, 4978-4985.
4. Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A and Transy C. (1999). Oncogene, 18, 2860-2871.
5. Blum HE, Zhang ZS, Galun E, von Weizsäcker F, Garner B, Liang TJ and Wands JR. (1992). J. Virol., 66, 1223-1227.
6. Bréchot C, Jaffredo F, Lagorce D, Gerken G, Meyer zum Büschenfelde K, Papakonstontinou A, Hadziyannis S, Romeo R, Colombo M, Rodes J, Bruix J and Naoumov N. (1998). J. Hepatol., 29, 173-183.
7. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH and Miller RH. (1993). J. Virol., 67, 1218-1226.
8. Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M, Fujita H, Yoshida M, Chen W, Asai A, Himeno MSY and Kuchino Y. (1999). Oncogene, 18, 2281.
9. Chirillo P, Pagano S, Natoli G, Puri PL, Burgío VL, Balsano C and Levrero M. (1997). Proc. Natl. Acad. Sci. USA, 94, 8162-8167.
10. Cory S and Adams JM. (1998). Biochim. Biophys. Acta, 1377, R25-R44.
11. Cuende E, Ales-Martinez JE, Liyun D, Gonzalez-Garcia M, Martinez-A C and Nunez G. (1993). EMBO J., 12, 1555-1560.
12. Dimri GP, Nakanishi M, Desprez PY, Smith JR and Campisi J. (1996). Mol. Cell. Biol., 16, 2987-2997.
13. Doria M, Klein N, Lucito R and Schneider RJ. (1995). EMBO J., 14, 4747-4757.
14. el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 2910-2919.
15. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H and Harris CC. (1997). Proc. Natl. Acad. Sci. USA, 94, 14707-14712.
16. Finlay CA, Hinds PW and Levine AJ. (1989). Cell, 57, 1083-1093.
17. Gottlob K, Fulco M, Levrero M and Graessmann A. (1998a). J. Biol. Chem., 273, 33347-33353.
18. Gottlob K, Pagano S, Levrero M and Graessmann A. (1998b). Cancer Res., 58, 3566-3570.
19. Haas K, Johannes C, Geisen C, Schmidt T, Karsunky H, Blass Kampmann S, Obe G and Möröy T. (1997). Oncogene, 15, 2615-2623.
20. Höhne M, Schaefer S, Seifer M, Feitelson MA, Paul D and Gerlich WH. (1990). EMBO J., 9, 1137-1145.
21. Kairat A, Beerheide W, Zhou G, Tang ZY, Edler L and Schröder CH. (1999). Intervirology, 42, 228-237.
22. Kekulé AS, Lauer U, Weiss L, Luber B and Hofschneider PH. (1993). Nature, 361, 742-745.
23. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B. (1992). Science, 256, 827-830.
24. Khosravi-Far R, Campbell S, Rossman KL and Der CD. (1998). Adv. Cancer Res., 72, 57-107.
25. Kim H, Lee H and Yun Y. (1998). J. Biol. Chem., 273, 381-385.
26. Klein NP and Schneider RJ. (1997). Mol. Cell. Biol., 17, 6427-6436.
27. Land H. (1995). Methods Enzymol., 254, 37-41.
28. Land H, Parada LF and Weinberg RA. (1983). Nature, 304, 596-602.
29. Lara-Pezzi E, Armesilla AL, Majano PL, Redondo JM and Lopez-Cabrera M. (1998). EMBO J., 17, 7066-7077.
30. Lee YH and Yun Y. (1998). J. Biol. Chem., 273, 25510 25515.
31. Natoli G, Avantaggiati ML, Chirillo P, Puri PL, Ianni A, Balsano C and Levrero M. (1994). Oncogene, 9, 2837-2843.
32. Oguey D, Dumenco LL, Pierce RH and Fausto N. (1996). Hepatology, 24, 1024-1033.
33. Olson MF, Paterson HF and Marshall CJ. (1998). Nature, 394, 295-299.
34. Parker GA, Crook T, Bain M, Sara EA, Farrell PJ and Allday MJ. (1996). Oncogene, 13, 2541-2549.
35. Peacock JW, Matlashewski GJ and Benchimol S. (1990). Oncogene, 1769-1774.
36. Peli J, Schröter M, Rudaz C, Hahne M, Meyer C, Reichmann E and Tschopp J. (1999). EMBO J., 18, 1824-1831.
37. Ponchel F, Puisieux A, Tabone E, Michot JP, Froschl G, Morel AP, Frebourg T, Fontaniere B, Oberhammer F and Ozturk M. (1994). Cancer Res., 54, 2064-2068.
38. Poussin K, Dienes H, Sirma H, Urban S, Beaugrand M, Franco D, Schirmacher P, Brechot C and Paterlini Brechet P. (1999). Int. J. Cancer, 80, 497-505.
39. Qi X-M, He H, Zhong H and Distelhorst CW. (1997). EMBO J., 15, 1207-1212.
40. Rakotomahanina CK, Hilger C, Fink T, Zentgraf H and Schroder CH. (1994). Oncogene, 9, 2613-2621.
41. Runkel L, Fischer M and Schaller H. (1993). Virology, 197, 529-536.
42. Schaefer S. (1999). Advances in Oncology. Vol. 3. Viruses, Cell Transformation and Cancer. Grand RJA. (ed.). JAI Press: Greenwich.
43. Schaefer S and Gerlich WH. (1995). Intervirology, 38, 143-154.
44. Schaefer S, Seifer M, Grimmsmann T, Fink L, Wenderhold S, Höhne MW and Gerlich WH. (1998). J. Gen. Virol., 79, 767-777.
45. Schlüter V, Meyer M, Hofschneider PH, Koshy R and Caselmann WH. (1994). Oncogene, 9, 3335-3344.
46. Seeger C, Baldwin B and Tennant BC. (1989). J. Virol., 63, 4665-4669.
47. Seifer M, Heermann KH and Gerlich WH. (1990a). Virology, 179, 287-299.
48. Seifer M, Heermann KH and Gerlich WH. (1990b). Virology, 179, 300-311.
49. Seifer M, Höhne M, Schaefer S and Gerlich WH. (1991a). J. Hepatol., 13, S61-S65.
50. Seifer M, Höhne M Schaefer S and Gerlich WH. (1991b). Viral Hepatitis-1990. Hollinger F, Lemon S and Margolis H. (eds). Williams and Wilkins: New York, pp. 586-588.
51. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M and Koike K. (1989). Jpn. J. Cancer Res., 80, 617-621.
52. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D and Brechot C. (1999). Oncogene, 18, 4848-4859.
53. Spandau DF and Lee CH. (1988). J. Virol., 62, 427-434.
54. Su F and Schneider RJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 8744-8749.
55. Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC and Kroemer G. (1997). J. Exp. Med., 186, 25-37.
56. Tarn C, Bilodeau ML, Hullinger RL and Andrisani OM. (1999). J. Biol. Chem., 274, 2327-2336.
57. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P and Buendia MA. (1998). Oncogcne, 17, 2115-2123.
58. Twu JS, Lai MY, Chen DS and Robinson WS. (1993). Virolog, 192, 346-350.
59. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JH and Harris CC. (1995). Cancer Res., 55, 6012-6016.
60. White E, Cipriani R, Sabbatini P and Denton A. (1991). J. Virol., 65, 2968-2978.
61. Yen TSB. (1996). J. Biomcd. Sci., 3, 20-30.
62. Zoulim F, Saputelli J and Seeger C. (1994). J. Virol., 68, 2026-2030.